Details for 2021755119

Up to date per 03.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT (S)-4-(4-(4-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)PIPERAZIN-1-YL)-3-FLUORBENZONITRIL UND VERFAHREN ZUR VERWENDUNG DAVON

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021755119

EP Publication Number

4178548

E-Number

1705642

Language

PCT Number

US21040452

Publication Date

17.05.2023 A

24.07.2024 B1

Registration Date

24.07.2024

AT Publication Date

15.08.2024

Application Date

06.07.2021

Registration Number

Priorities

07.07.2020

202063048998 P

IPC

A61K 9/16 20060101AFI20240110BHEP

Maximum Duration of Protection

06.07.2041

Owner

Celgene CorporationRoute 206 & Province Line Road Princeton, NJ 08543US

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

AGRAWAL, Anjali Summit, NJ 07901US

MITRA, Biplob, K. Summit, NJ 07901US

THOOL, Prajwal, Gunwanth Summit, NJ 07901US

HIGGINS-GRUBER, Shannon Summit, NJ 07901US

RODRIGUEZ, Jennifer, Almodovar Summit, NJ 07901US

LIU, Demin Summit, NJ 07901US

Information about Fees